Please assess the completion status of the following clinical trial:

Trial Title: Phase I Dose Escalation of Stereotactic Radiosurgical Boost for Locally Advanced Esophageal Cancer

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:- Confirmed diagnosis of adenocarcinoma or squamous cell carcinoma of the esophagus by pathologist.~* Endoscopic ultrasound or CT evidence of tumor penetration through the esophageal wall or involvement of regional lymph nodes, without evidence of distant metastasis~* No prior chest radiation therapy~* No prior chemotherapy for esophageal cancer~* Age greater than 18 years~* No infections requiring antibiotic treatment~* Able to care for self~* Patients must have acceptable liver, kidney and bone marrow function.~* The effects of the chemotherapy drugs on the developing human fetus are unknown. Women of child-bearing potential and men must agree to use adequate contraception. Exclusion Criteria:- Patients receiving any other investigational agents~* Evidence of distant metastases~* Uncontrolled medical illness~* Any malignancy other than non-melanoma skin cancer or carcinoma in situ of the cervix.~* Pregnant and breastfeeding women are excluded.~* HIV-positive patients

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).